Chemotherapy-induced peripheral neurotoxicity: a critical analysis
- PMID: 24590861
- DOI: 10.3322/caac.21204
Chemotherapy-induced peripheral neurotoxicity: a critical analysis
Abstract
With a 3-fold increase in the number of cancer survivors noted since the 1970s, there are now over 28 million cancer survivors worldwide. Accordingly, there is a heightened awareness of long-term toxicities and the impact on quality of life following treatment in cancer survivors. This review will address the increasing importance and challenge of chemotherapy-induced neurotoxicity, with a focus on neuropathy associated with the treatment of breast cancer, colorectal cancer, testicular cancer, and hematological cancers. An overview of the diagnosis, symptomatology, and pathophysiology of chemotherapy-induced peripheral neuropathy will be provided, with a critical analysis of assessment strategies, neuroprotective approaches, and potential treatments. The review will concentrate on neuropathy associated with taxanes, platinum compounds, vinca alkaloids, thalidomide, and bortezomib, providing clinical information specific to these chemotherapies.
Keywords: chemotherapy; neuropathy; neurotoxicity; survivorship.
© 2013 American Cancer Society, Inc.
Similar articles
-
Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies.Neth J Med. 2012 Jan;70(1):18-25. Neth J Med. 2012. PMID: 22271810 Review.
-
Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies.Curr Med Chem. 2008;15(29):3081-94. doi: 10.2174/092986708786848569. Curr Med Chem. 2008. PMID: 19075655 Review.
-
Chemotherapy-Induced Peripheral Neuropathy in Long-term Survivors of Childhood Cancer: Clinical, Neurophysiological, Functional, and Patient-Reported Outcomes.JAMA Neurol. 2018 Aug 1;75(8):980-988. doi: 10.1001/jamaneurol.2018.0963. JAMA Neurol. 2018. PMID: 29799906 Free PMC article.
-
Nerve excitability assessment in chemotherapy-induced neurotoxicity.J Vis Exp. 2012 Apr 26;(62):3439. doi: 10.3791/3439. J Vis Exp. 2012. PMID: 22565594 Free PMC article.
-
Quantification of Small Fiber Neuropathy in Chemotherapy-Treated Patients.J Pain. 2020 Jan-Feb;21(1-2):44-58. doi: 10.1016/j.jpain.2019.06.011. Epub 2019 Jul 17. J Pain. 2020. PMID: 31325646 Review.
Cited by
-
Reliability testing of oxaliplatin-associated neurotoxicity questionnaire (OANQ), a pilot study.Support Care Cancer. 2016 Feb;24(2):747-754. doi: 10.1007/s00520-015-2838-y. Epub 2015 Jul 4. Support Care Cancer. 2016. PMID: 26137985
-
Perceived Stress Levels, Chemotherapy, Radiation Treatment and Tumor Characteristics Are Associated with a Persistent Increased Frequency of Somatic Chromosomal Instability in Women Diagnosed with Breast Cancer: A One Year Longitudinal Study.PLoS One. 2015 Jul 15;10(7):e0133380. doi: 10.1371/journal.pone.0133380. eCollection 2015. PLoS One. 2015. PMID: 26177092 Free PMC article.
-
Targeting therapy-induced senescence as a novel strategy to combat chemotherapy-induced peripheral neuropathy.Support Care Cancer. 2024 Jan 5;32(1):85. doi: 10.1007/s00520-023-08287-0. Support Care Cancer. 2024. PMID: 38177894 Review.
-
Radiation and chemotherapy for high-risk lower grade gliomas: Choosing between temozolomide and PCV.Cancer Med. 2020 Jan;9(1):3-11. doi: 10.1002/cam4.2686. Epub 2019 Nov 7. Cancer Med. 2020. PMID: 31701682 Free PMC article. Review.
-
Perturbations in neuroinflammatory pathways are associated with paclitaxel-induced peripheral neuropathy in breast cancer survivors.J Neuroimmunol. 2019 Oct 15;335:577019. doi: 10.1016/j.jneuroim.2019.577019. Epub 2019 Aug 2. J Neuroimmunol. 2019. PMID: 31401418 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
